IL-6 signaling has been previously suggested as a biomarker for asthma [45–47] and circulating levels of IL-6 has been shown to be increased in individuals with asthma [47] and has been associated with high dose ICS in adult onset asthma [45]. The gene discussed is IL6; the disease is asthma.